Back to search

Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy

Data up to Jan 2025

Published1999
Citations152
References31

Total Citations Per Year

Abstract

References (31)

Analysis of serial measurements in medical research.

1990 • 3,078 citations

Transforming Growth Factor β in Tissue Fibrosis

1994 • 3,055 citations

International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology

1993 • 1,431 citations

A Fluorometric Assay for the Measurement of Nitrite in Biological Samples

1993 • 1,022 citations

Transforming Growth Factor‐β

1990 • 696 citations

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

1995 • 668 citations

Molecular insights into renal interstitial fibrosis.

1996 • 636 citations

Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis

1998 • 441 citations

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

1998 • 222 citations

Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy

1997 • 207 citations

HISTOLOGICAL CHRONIC ALLOGRAFT DAMAGE INDEX ACCURATELY PREDICTS CHRONIC RENAL ALLOGRAFT REJECTION

1994 • 199 citations

Evidence that TGF-β should be a therapeutic target in diabetic nephropathy

1998 • 148 citations

Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells

1997 • 115 citations

Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.

1994 • 111 citations

IN VIVO HYPEREXPRESSION OF TRANSFORMING GROWTH FACTOR-??1 IN MICE: STIMULATION BY CYCLOSPORINE1

1997 • 109 citations

Angiotensin II Induces Hypertrophy of Human Airway Smooth Muscle Cells: Expression of Transcription Factors and Transforming Growth Factor- β1

1998 • 100 citations

Expression of TGF-β1 and matrix proteins is elevated in rats with chronic rejection

1996 • 92 citations

Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients

1998 • 89 citations

Suppression of Interleukin-1β-induced Nitric-oxide Synthase Promoter/Enhancer Activity by Transforming Growth Factor-β1 in Vascular Smooth Muscle Cells

1996 • 78 citations

Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis

1998 • 77 citations

Efficacy and safety of losartan in the treatment of hypertension in renal transplant recipients

1998 • 71 citations

Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives

1990 • 67 citations

TGFβ—a role in systemic sclerosis?

1998 • 63 citations

Altered expression of transforming growth factor-βs in chronic renal rejection

1996 • 50 citations

Changes of Plasma Endothelin and Growth Factor Levels, and of Left Ventricular Mass, After Chronic AT1-Receptor Blockade in Human Hypertension

1998 • 43 citations

Immunologic determinants of susceptibility to experimental glomerulonephritis: Role of cellular immunity

1997 • 29 citations

Physiological role of endothelin in cardiovascular and renal hemodynamics: studies in animals

1997 • 28 citations

Chronic rejection.

1994 • 28 citations

Role of TGF-β in Vascular Development and Vascular Reactivity

1998 • 28 citations

Chronic rejection ‐ Definition and correlates

1994 • 24 citations

Interaction of the Renin-Angiotensin System and the Endothelin System in Cardiac Hypertrophy

1998 • 9 citations

Cited By (0)

Loading...
Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft… (1999) – Kidney International | Metascience Observatory Explorer